$7.31
0.020.27%
Ult. Agg.: Oct 29, 5:48 PM
Ocular Therapeutix (OCUL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ocular Therapeutix (OCUL) ha pubblicato l'ultima guidance il novembre 7, 2023 per fiscal year 2023. La società ha previsto un fatturato pari a $60M - $60M per il periodo.
Rispetto alle previsioni precedenti, Ocular Therapeutix ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Ocular Therapeutix ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Ocular Therapeutix. 4
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.39 | $-0.32 | $-0.33 | $-0.36 |
| Actual | $-0.35 | $-0.40 | $-0.29 | $-0.38 |
| Surprise | +10.3% | -25.0% | +12.1% | -5.56% |
| Revenue | ||||
| Estimate | $13.1M | $12.7M | $15.7M | $14.1M |
| Actual | $13.5M | $10.8M | $13.3M | $14.5M |
| Surprise | +2.89% | -15.1% | -15.7% | +3.25% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.38 | $-0.38 | $-0.37 |
| Revenue | ||||
| Consensus | $14.2M | $14.1M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $-0.35 | $-0.39 | 10.3 % |
| Q1 | May 5, 2026 | $-0.40 | $-0.32 | -25.0 % |
| Q4 | Feb 5, 2026 | $-0.29 | $-0.33 | 12.1 % |
| Q3 | Nov 4, 2025 | $-0.38 | $-0.36 | -5.56 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $13.48M | $13.10M | 2.89 % |
| Q1 | May 5, 2026 | $10.79M | $12.71M | -15.1 % |
| Q4 | Feb 5, 2026 | $13.25M | $15.73M | -15.7 % |
| Q3 | Nov 4, 2025 | $14.54M | $14.09M | 3.25 % |